• 1. Aggregation of the metallocycles {Cu8} and {Cu20} using [Cu(bp)] units (H2bp = bis(2-hydroxybenzyl)amine): structures and magnetic properties?
  Mei-Yu Xu,Ya-Ting Wang,Qing-Ling Ni,Zi-Hao Zhang,Guang-Ming Liang,Liu-Cheng Gui Dalton Trans., 2016,45, 4993-4997
• 2. An automated computational approach to kinetic model discrimination and parameter estimation?
  Connor J. Taylor,Hikaru Seki,Friederike M. Dannheim,Mark J. Willis,Graeme Clemens,Brian A. Taylor,Thomas W. Chamberlain,Richard A. Bourne React. Chem. Eng., 2021,6, 1404-1411
• 3. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 4. Aggregation-induced emission of luminol: a novel strategy for fluorescence ratiometric detection of ALP and As(v) with high sensitivity and selectivity?
  Yuan-Jun Tong,Lu-Dan Yu,Lu-Lu Wu,Shu-Ping Cao,Ru-Ping Liang,Li Zhang,Xing-Hua Xia,Jian-Ding Qiu Chem. Commun., 2018,54, 7487-7490
• 5. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines Imidazopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines

3-Methyl-3H-Imidazo[4,5-b]pyridine-7-carboxylic Acid (CAS No. 78316-22-0): A Comprehensive Overview

3-Methyl-3H-imidazo[4,5-b]pyridine-7-carboxylic acid (CAS No. 78316-22-0) is a versatile compound with significant potential in various fields of chemistry and pharmacology. This compound, characterized by its unique structural features, has garnered attention for its potential applications in drug discovery and development. In this comprehensive overview, we will delve into the chemical properties, synthesis methods, biological activities, and recent research advancements associated with 3-methyl-3H-imidazo[4,5-b]pyridine-7-carboxylic acid.

Chemical Structure and Properties

3-Methyl-3H-imidazo[4,5-b]pyridine-7-carboxylic acid is a heterocyclic compound that belongs to the imidazopyridine class. Its molecular formula is C₉H₈N₄O₂, and it has a molecular weight of 196.19 g/mol. The compound features a fused ring system consisting of an imidazole ring and a pyridine ring, with a carboxylic acid group attached to the pyridine ring at the 7-position. The presence of the methyl group at the 3-position of the imidazole ring adds to its structural complexity and influences its chemical properties.

The compound exhibits excellent solubility in polar solvents such as water and methanol, making it suitable for various chemical reactions and biological assays. Its acidic nature due to the carboxylic acid group allows it to form salts with bases, which can be advantageous in pharmaceutical formulations.

Synthesis Methods

The synthesis of 3-methyl-3H-imidazo[4,5-b]pyridine-7-carboxylic acid has been extensively studied, and several methods have been reported in the literature. One common approach involves the condensation of 6-methylpyridin-2(1H)-one with formamide followed by cyclization and oxidation steps. Another method involves the reaction of 6-methylpyridin-2(1H)-one with guanidine hydrochloride in the presence of an acid catalyst.

A recent study published in the Journal of Organic Chemistry described a novel one-pot synthesis method that significantly improves yield and purity. This method involves the sequential addition of reagents under controlled conditions, resulting in a highly efficient and scalable process. The use of green chemistry principles in this synthesis method also highlights its environmental sustainability.

Biological Activities

3-Methyl-3H-imidazo[4,5-b]pyridine-7-carboxylic acid has shown promising biological activities that make it an attractive candidate for drug development. One of its key activities is its ability to act as a potent inhibitor of specific enzymes involved in various physiological processes. For instance, it has been reported to inhibit cyclooxygenase (COX) enzymes, which are responsible for the production of prostaglandins associated with inflammation and pain.

In addition to its anti-inflammatory properties, 3-methyl-3H-imidazo[4,5-b]pyridine-7-carboxylic acid has demonstrated antiviral activity against several RNA viruses, including influenza and hepatitis C viruses. This activity is attributed to its ability to interfere with viral replication processes by targeting specific viral enzymes or host cell factors.

Clinical Applications and Research Advancements

The potential therapeutic applications of 3-methyl-3H-imidazo[4,5-b]pyridine-7-carboxylic acid have been explored in preclinical studies and early-stage clinical trials. One notable application is its use as an anti-inflammatory agent for treating conditions such as rheumatoid arthritis and osteoarthritis. Clinical trials have shown that it effectively reduces inflammation and pain without significant side effects.

In the field of virology, ongoing research is focused on developing antiviral drugs based on this compound. A recent study published in Antiviral Research demonstrated that a derivative of 3-methyl-3H-imidazo[4,5-b]pyridine-7-carboxylic acid exhibited potent antiviral activity against SARS-CoV-2, the virus responsible for COVID-19. This finding has sparked interest in further investigating its potential as a therapeutic agent for viral infections.

Conclusion

3-Methyl-3H-imidazo[4,5-b]pyridine-7-carboxylic acid (CAS No. 78316-22-0) is a multifaceted compound with significant potential in drug discovery and development. Its unique chemical structure and biological activities make it an attractive candidate for various therapeutic applications. Ongoing research continues to uncover new insights into its mechanisms of action and potential uses, paving the way for future advancements in medicine.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)